Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Acute, Rapid Lowering of Low Density Lipoprotein Cholesterol With Alirocumab in Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

NCT03718286 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT03718286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03718286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Acute, Rapid Lowering of Low Density Lipoprotein Cholesterol With Alirocumab in Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Lead sponsor
Population Health Research Institute
Phase
Phase 2
Overall status
Completed
Start date
March 11, 2019
Completion date
October 8, 2021
Enrollment
97 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, dyslipidemias, hypercholesterolemia, hyperlipidemias, physiological effects of drugs, st elevation myocardial infarction